Table 5 The association between cognitive performance and total VB2 intake stratified by gender
From: Association of vitamin B2 intake with cognitive performance in older adults: a cross-sectional study
Cognitive tests | OR1 | 95% CI1 | P1 |
|---|---|---|---|
CERAD Delayed Recall | |||
Male | 1.00 | 0.97, 1.03 | 0.993 |
Female | 1.00 | 0.99, 1.02 | 0.698 |
CERAD Trial 1 Recall | |||
Male | 1.02 | 1.00, 1.04 | 0.054 |
Female | 1.00 | 0.99, 1.02 | 0.677 |
CERAD Trial 2 Recall | |||
Male | 1.02 | 1.01, 1.04 | 0.001 |
Female | 1.00 | 1.00, 1.01 | 0.211 |
CERAD Trial 3 Recall | |||
Male | 1.01 | 1.00, 1.03 | 0.083 |
Male | 1.01 | 1.00, 1.03 | 0.083 |
CERAD total | |||
Male | 1.06 | 1.01, 1.11 | 0.015 |
Female | 1.01 | 0.99, 1.04 | 0.246 |
AFT | |||
Male | 1.00 | 0.95, 1.05 | 0.981 |
Female | 1.00 | 0.97, 1.02 | 0.682 |
DSST | |||
Male | 1.07 | 0.95, 1.20 | 0.244 |
Female | 1.01 | 0.93, 1.09 | 0.804 |